Progression of Metastatic Pancreatic Cancer
6 意见
• 07/30/23
0
0
嵌入
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论